CN Patent

CN1319958C — 作为血清素再摄取抑制剂的苯基哌嗪衍生物

Assigned to H Lundbeck AS · Expires 2007-06-06 · 19y expired

What this patent protects

本发明提供通式I化合物，其中取代基定义如说明书中所定义。本发明还涉及所述化合物及其药学上可接受的酸加成盐用于制备治疗情感障碍，如抑郁症，包括一般的焦虑疾病和恐慌疾病的焦虑疾病以及强迫性的强制的疾病的药物的用途。

USPTO Abstract

本发明提供通式I化合物，其中取代基定义如说明书中所定义。本发明还涉及所述化合物及其药学上可接受的酸加成盐用于制备治疗情感障碍，如抑郁症，包括一般的焦虑疾病和恐慌疾病的焦虑疾病以及强迫性的强制的疾病的药物的用途。

Drugs covered by this patent

vortioxetine-hydrobromide (VORTIOXETINE HYDROBROMIDE)

Patent Metadata

Patent number: CN1319958C
Jurisdiction: CN
Classification: —
Expires: 2007-06-06
Drug substance claim: No
Drug product claim: No
Assignee: H Lundbeck AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.